Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ DOCUSATE SODIUM SANDOZ CANADA INCORPORATED Actual shortage 100MG Updated Report 2024-05-01 219987
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Actual shortage 325MG 5MG Updated Report 2024-05-01 224972
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Actual shortage 325MG 5MG Updated Report 2024-05-01 224969
SANDOZ D 10 000 SANDOZ CANADA INCORPORATED Actual shortage 10000UNIT Updated Report 2024-05-01 225223
THYROGEN SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC Resolved 0.9MG Updated Report 2024-05-01 191764
SANDOZ EZETIMIBE SANDOZ CANADA INCORPORATED Resolved 10MG Updated Report 2024-05-01 222611
SANDOZ OLMESARTAN SANDOZ CANADA INCORPORATED Resolved 20MG Updated Report 2024-05-01 223197
SANDOZ RIVASTIGMINE PATCH 10 SANDOZ CANADA INCORPORATED Resolved 9.5MG Updated Report 2024-05-01 224174
SOLU-CORTEF PFIZER CANADA ULC Actual shortage 250MG Updated Report 2024-05-01 225355
SANDOZ EVEROLIMUS SANDOZ CANADA INCORPORATED Resolved 5MG Updated Report 2024-05-01 225965

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ DOCUSATE SODIUM SANDOZ CANADA INCORPORATED To be discontinued 100MG New Report 2024-05-01 226758
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED To be discontinued 325MG 5MG New Report 2024-05-01 226753
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED To be discontinued 325MG 5MG New Report 2024-05-01 226748
SANDOZ D 10 000 SANDOZ CANADA INCORPORATED To be discontinued 10000UNIT New Report 2024-05-01 226738
PANECTYL SEARCHLIGHT PHARMA INC To be discontinued 2.5MG New Report 2024-04-30 226633